Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane A Mitchell

Showing results (21-30 of 148) with videos related to

Pageof 15
Sort By:
European Journal of Pharmacology|February 23, 2002
Cytokine modulation of granulocyte macrophage-CSF and granulocyte-CSF release from stimulated vascular smooth muscle cellsSalome J Stanford, John R Pepper, Jane A Mitchell
Lancet (London, England)|November 30, 2002
Cyclo-oxygenase-2 inhibitors and cardiovascular eventsTimothy D Warner, Jane A Mitchell, John R Vane
European Journal of Pharmacology|February 27, 2004
Carbon monoxide inhibits endothelin-1 release by human pulmonary artery smooth muscle cellsSalome J Stanford, Matthew J Walters, Jane A Mitchell
Methods in Molecular Biology (Clifton, N.J.)|April 11, 2019
Imaging of Tissue-Specific and Temporal Activation of GPCR Signaling Using DREADD Knock-In MiceDmitry Akhmedov, Nicholas S Kirkby, Jane A Mitchell, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 12, 2005
Cellular mechanisms of acetaminophen: role of cyclo-oxygenaseRuth Lucas, Timothy D Warner, Ivana Vojnovic, et al.
British Journal of Pharmacology|June 6, 2003
Endothelium-dependent relaxation and endothelial hyperpolarization by P2Y receptor agonists in rat-isolated mesenteric arteryHammit Mistry, Jonathan M Gitlin, Jane A Mitchell, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 13, 2006
Influence of plasma protein on the potencies of inhibitors of cyclooxygenase-1 and -2Timothy D Warner, Ivana Vojnovic, David Bishop-Bailey, et al.
British Journal of Clinical Pharmacology|June 19, 2012
Stem cell-derived endothelial cells for cardiovascular disease: a therapeutic perspectiveDaniel M Reed, Gabor Foldes, Sian E Harding, et al.
European Journal of Pharmacology|July 16, 2003
Type II nitric oxide synthase activity is cardio-protective in experimental sepsisSuzanna Price, Jane A Mitchell, Peter B Anning, et al.
Cytokine|January 25, 2003
Modulation by colony stimulating factors of human epithelial colon cancer cell apoptosisSara Calatayud, Timothy D Warner, Emma J Breese, et al.
Pageof 15

Showing results (21-30 of 148) with videos related to

Sort By:
Pageof 15
European Journal of Pharmacology|February 23, 2002
Cytokine modulation of granulocyte macrophage-CSF and granulocyte-CSF release from stimulated vascular smooth muscle cellsSalome J Stanford, John R Pepper, Jane A Mitchell
Lancet (London, England)|November 30, 2002
Cyclo-oxygenase-2 inhibitors and cardiovascular eventsTimothy D Warner, Jane A Mitchell, John R Vane
European Journal of Pharmacology|February 27, 2004
Carbon monoxide inhibits endothelin-1 release by human pulmonary artery smooth muscle cellsSalome J Stanford, Matthew J Walters, Jane A Mitchell
Methods in Molecular Biology (Clifton, N.J.)|April 11, 2019
Imaging of Tissue-Specific and Temporal Activation of GPCR Signaling Using DREADD Knock-In MiceDmitry Akhmedov, Nicholas S Kirkby, Jane A Mitchell, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 12, 2005
Cellular mechanisms of acetaminophen: role of cyclo-oxygenaseRuth Lucas, Timothy D Warner, Ivana Vojnovic, et al.
British Journal of Pharmacology|June 6, 2003
Endothelium-dependent relaxation and endothelial hyperpolarization by P2Y receptor agonists in rat-isolated mesenteric arteryHammit Mistry, Jonathan M Gitlin, Jane A Mitchell, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 13, 2006
Influence of plasma protein on the potencies of inhibitors of cyclooxygenase-1 and -2Timothy D Warner, Ivana Vojnovic, David Bishop-Bailey, et al.
British Journal of Clinical Pharmacology|June 19, 2012
Stem cell-derived endothelial cells for cardiovascular disease: a therapeutic perspectiveDaniel M Reed, Gabor Foldes, Sian E Harding, et al.
European Journal of Pharmacology|July 16, 2003
Type II nitric oxide synthase activity is cardio-protective in experimental sepsisSuzanna Price, Jane A Mitchell, Peter B Anning, et al.
Cytokine|January 25, 2003
Modulation by colony stimulating factors of human epithelial colon cancer cell apoptosisSara Calatayud, Timothy D Warner, Emma J Breese, et al.
Pageof 15